Interestingly, this study reported that the CD8/CD4 ratio and CD8/CD68 ratio were significantly reduced in metastatic tumors compared with the corresponding primary tumors, suggesting a tolerogenic and tumor-promoting microenvironment at the metastatic site. The gene discussed is CD4; the disease is neoplasm.